# A Study of Volociximab in Metastatic Melanoma

> **NCT00369395** · PHASE2 · TERMINATED · sponsor: **Abbott** · enrollment: 19 (actual)

## Conditions studied

- Stage IV Melanoma

## Interventions

- **DRUG:** volociximab

## Key facts

- **NCT ID:** NCT00369395
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Insufficient clinical activity
- **Last updated:** 2012-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00369395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00369395, "A Study of Volociximab in Metastatic Melanoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00369395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*